Abstract
Immunoglobulin G4-related disease (IgG4-RD) is an immune-mediated systemic disease that has a particular predilection for glandular and connective tissue, including orbital adnexa and the pachymeninges. IgG4-RD enters into the differential diagnoses of numerous inflammatory, infectious, and neoplastic disorders and has emerged as a unifying diagnosis for a number of conditions once considered unrelated but now recognized to be linked by consistent histopathological features across all organs affected. The histopathological hallmarks of IgG4-RD include a lymphoplasmacytic infiltrate with a predominance of IgG4-positive plasma cells, obliterative phlebitis, and storiform fibrosis. IgG4-RD generally responds well to high doses of glucocorticoids, but disease recurrences are common upon the tapering of glucocorticoids, and many patients are steroid dependent. Patients with IgG4-RD characterized by advanced fibrosis within affected organs may respond less readily to immunosuppressive therapy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kamisawa T, Egawa N, Nakajima H. Autoimmune pancreatitis is a systemic autoimmune disease. Am J Gastroenterol. 2003;98:2811–2.
Kamisawa T, Funata N, Hayashi Y, Eishi Y, Koike M, Tsuruta K, et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol. 2003;38:982–4.
Wallace ZS, Deshpande V, Stone JH. Ophthalmic manifestations of IgG4-related disease: single-center experience and literature review. Semin Arthritis Rheum. 2014;43:806–17.
Kamisawa T, Zen Y, Pillai S, Stone JH. IgG4-related disease. Lancet. 2015;385(9976):1460–71.
Ferry JA, Deshpande V. IgG4-related disease in the head and neck. Semin Diagn Pathol. 2012;29:235–44.
Ebbo M, Daniel L, Pavic M, Sève P, Hamidou M, Andres E, et al. IgG4-related systemic disease: features and treatment response in a French cohort: results of a multicenter registry. Medicine. 2012;91:49–56.
Von Mikulicz-Radecki J. Ueber eine eigenartige symmetrische erkrankung der thränen- und mundspeicheldrüsen. (A peculiar symmetrical disease of the lacrymal and salivary glands). In: Beiträge zur Chirurgie. Festschrift gewidmet Theodor Billroth. Stuttgart: Ferdinand Enke; 1892. p. 610–30. German.
Morgan WS, Castleman B. A clinicopathologic study of “Mikulicz’s disease”. Am J Pathol. 1953;29(3):471–503.
Ikeda T, Oka M, Shimizu H, Hatakeyama M, Kanki H, Kunisada M, et al. IgG4-related skin manifestations in patients with IgG4-related disease. Eur J Dermatol. 2013;23(2):241–5.
Boonstra K, Culver EL, de Buy Wenniger LM, van Heerde MJ, van Erpecum KJ, Poen AC, et al. Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitis. Hepatology. 2014;59:1954–63.
Khosroshahi A, Cheryk LA, Carruthers MN, Edwards JA, Bloch DB, Stone JH. Brief report: spuriously low IgG4 concentrations caused by the prozone phenomenon in patients with IgG4-related disease. Arthritis Rheumatol. 2014;66(1):213–7.
Wallace ZS, Mattoo H, Carruthers MN, Mahajan VS, Della Torre E, Lee H, et al. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Ann Rheum Dis. 2014;74(1):190–5.
Sato Y, Notohara K, Kojima M, Takata K, Masaki Y, Yoshino T. IgG4-related disease: historical overview and pathology of hematological disorders. Pathol Int. 2010;60:247–58.
Nakatani K, Nakamoto Y, Togashi K. Utility of FDG PET/CT in IgG4-related systemic disease. Clin Radiol. 2012;67:297–305.
Lighaam LC, Aalberse RC, Rispens T. IgG4-related fibrotic diseases from an immunological perspective: regulators out of control? Int J Rheumatol. 2012;2012:789164, 6 pages.
Noshiro S, Wanibuchi M, Akiyama Y, Okawa S, Ohtaki S, Sugino T, et al. IgG4-related disease initially presented as an orbital mass lesion mimicking optic nerve sheath meningioma. Brain Tumor Pathol. 2015;32:286–90.
Kocabeyoglu S, Karadag O, Mocan MC, Erden A, Irkec M. Orbital involvement and ocular surface changes in IgG4-related systemic disease. Cornea. 2016;35(11):1449–53.
Cheuk W, Yuen HKL, Chan CL, Shih LY, Kuo TT, Ma MW, et al. Ocular adnexal lymphoma associated with IgG4+ chronic sclerosing dacryoadenitis: a previously undescribed complication of IgG4-related sclerosing disease. Am J Surg Pathol. 2008;32(8):1159–67.
Wallace ZS, Wallace CJ, Lu N, Choik HK, Stone JH. Association of IgG4-related disease with history of malignancy. Arthritis Rheumatol. 2016;68(9):2283–9.
Katsura M, Mori H, Kunimatsu A, Sasaki H, Abe O, Machida T, et al. Radiological features of IgG4-related disease in the head, neck and brain. Neuroradiology. 2012;54:873–82.
Song YS, Choung HK, Park SW, Kim JH, Khwarg SI, Jeon YK. Ocular adnexal IgG4-related disease: CT and MRI findings. Br J Ophthalmol. 2013;97:412–8.
Ohshima K, Sogabe Y, Sato Y. The usefulness of infraorbital nerve enlargement on MRI imaging in clinical diagnosis of IgG4-related orbital disease. Jpn J Ophthalmol. 2012;56:380–2.
Ben Soussan J, Deschamps R, Sadik JC, Savatovsky J, Deschamps L, Puttermann M, et al. Infraorbital nerve involvement on magnetic resonance imaging in European patients with IgG4-related ophthalmic disease: a specific sign. Eur Radiol. 2017;27(4):1335–43.
Wallace ZS, Carruthers MN, Khosroshahi A, Carruthers R, Shinagare S, Stemmer-Rachamimov A, et al. IgG4-related disease and hypertrophic pachymeningitis. Medicine. 2013;92:206–16.
Kim EH, Kim SH, Cho JM, Ahn JY, Chang JH. Immunoglobulin G4-related hypertrophic pachymeningitis involving cerebral parenchyma. J Neurosurg. 2011;115:1242–7.
Regev K, Nusbaum T, Cagnano E, Giladi N, Karni A. Central nervous system manifestation of IgG4-related disease. JAMA Neurol. 2014;71(6):767–70.
Lu LX, Della-Torre E, Stone JH, Clark SW. IgG4-related hypertrophic pachymeningitis. Clinical features, diagnostic criteria, and treatment. JAMA Neurol. 2014;71(6):785–93.
Li L, Tse PH, Tsang FC, Lo RC, Lui WM, Leung GK. IgG4-related hypertrophic pachymeningitis at the falx cerebri with brain parenchymal invasion: a case report. World Neurosurg. 2015;84(2):591.E7–E10.
Williams MW, Mashaly H, Puduvalli VK, Jin M, Mendel E. Immunoglobulin G4-related disease mimicking an epidural spinal cord tumor: case report. J Neurosurg Spine. 2017;26(1):76–80.
Lindstrom KM, Cousar JB, Lopes MBS. IgG4-related meningeal disease: clinic-pathological features and proposal for diagnostic criteria. Acta Neuropathol. 2010;120:765–76.
Inoue D, Zen Y, Sato Y, Abo H, Demachi H, Uchiyama A, et al. IgG4-related perineural disease. Int J Rheumatol. 2012;2012:401890.
Shimatsu A, Oki Y, Fujisawa I, Sano T. Pituitary and stalk lesions (infundibulo-hypophysitis) associated with immunoglobulin G4-related systemic disease: an emerging clinical entity. Endocr J. 2009;56(9):1033–41.
Barp A, Fedrigo M, Farina FM, Lepidi S, Causin F, Castellani C, et al. Carotid aneurism with acute dissection: an unusual case of IgG4-related diseases. Cardovasc Pathol. 2016;25:59–62.
Monach PA, Stone JH, Sharma A, Nazarian RM. Case 6-2017. A 57-year-old woman with fatigue, sweats, weight loss, headache, and skin lesions. N Engl J Med. 2017;376(8):775–86.
Aalberse RC, Dieges PH, Knul-Bretlova V, Vooren P, Aalbers M, van Leeuwen J. IgG4 as a blocking antibody. Clin Rev Allergy. 1983;1:289–302.
van de Veen W, Stanic B, Yaman G, Wawrzyniak M, Söllner S, Akdis DG, et al. IgG4 production is confined to human IL-10 producing regulatory B cells that suppress antigen-specific immune responses. J Allergy Clin Immunol. 2013;131(4):1204–12.
Lighaam LC, Vermeulen E, den Bleker TD, Meijlink KJ, Aalberse RC, Barnes E, et al. Phenotypic differences between IgG4 + and IgG1 + B cells point to distinct regulation of the IgG4 response. J Allergy Clin Immunol. 2013;133(1):267–70.
van der Neut Kolfschoten M, Schuurman J, Losen M, Bleeker WK, Martínez-Martínez P, Vermeulen E, et al. Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange. Science. 2007;317(5844):1554–7.
Mattoo H, Mahajan VS, Maehara T, Deshpande V, Della-Torre E, Wallace ZS, et al. Clonal expansion of CD4(+) cytotoxic T lymphocytes in patients with IgG4-related disease. J Allergy Clin Immunol. 2016;138(3):825–38.
Perugino CA, Stone JH. Treatment of IgG4-related disease: current and future approaches. Z Rheumatol. 2016;75(7):681–6.
Carruthers M, Topazian M, Khosroshahi A, Witzig TE, Wallace ZS, Hart PA, et al. Rituximab for IgG4-related disease: a prospective, open-label trial. Ann Rheum Dis. 2015;74:1171–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Chwalisz, B.K., Stone, J.H. (2019). Neurologic Complications of Immunoglobulin G4-Related Disease (IgG4-RD). In: Cho, T., Bhattacharyya, S., Helfgott, S. (eds) Neurorheumatology. Springer, Cham. https://doi.org/10.1007/978-3-030-16928-2_10
Download citation
DOI: https://doi.org/10.1007/978-3-030-16928-2_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-16927-5
Online ISBN: 978-3-030-16928-2
eBook Packages: MedicineMedicine (R0)